Home › Type 1 Diabetes › California

Pag-aaral pangklinika para sa Type 1 Diabetes sa California

38 pag-aaral para sa Type 1 Diabetes ang naghahanap ng mga kalahok sa mga site sa California.

Mga Lungsod sa California

Opisyal na teksto ng pag-aaral (English)

Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

ProSciento, Chula Vista
Headlands Research California LLC, Escondido
Stanford University, Palo Alto
at 4 pa

Nagre-recruit

Edad 2 hanggang 80 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07864168

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

Rady Children's Hospital- Site Number : 8400002, San Diego
University of California San Francisco - Mission Bay- Site Number : 8400011, San Francisco

Nagre-recruitPhase 3

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT07088068

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Hoag Memorial Hospital, Newport Beach
Rady Children's Hospital San Diego, San Diego
Diablo Clinical Research, Walnut Creek

Nagre-recruitPhase 1/2

Edad 12 hanggang 35 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06783309

Food Insecurity Reduction & Strategy Team

Stanford Medicine, Palo Alto

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06329375

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems

Paradigm Clinical Research -Modesto, Modesto
Paradigm Clinical Research Centers, LLC, San Diego

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07616206

C-Carbs: A CGM-guided Approach to Teaching Carb Awareness

University of California Los Angeles, Los Angeles

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07807280

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

Sansum Diabetes Research Institute, Santa Barbara

Nagre-recruitPhase 3

Edad 1 hanggang 35 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07222137

Closed Loop and Education for Hypoglycemia Awareness Restoration

University of California, San Diego, La Jolla

Nagre-recruit

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06325202

Starting Technology in At Risk Type 1 Diabetes Study

UCLA, Santa Monica
Olive View-UCLA Medical Center, Sylmar
Harbor-UCLA Medical Center, Torrance

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06453928

Denosumab for Type 1 Diabetes

City of Hope Medical Center, Duarte

Nagre-recruitPhase 1/2

Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06524960

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

City of Hope Medical Center, Duarte
University of California - San Diego, San Diego
University of California - San Francisco, San Francisco

Nagre-recruitPhase 1

Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT06919354

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

UCLA, Los Angeles
UCSF, San Francisco

Nagre-recruitPhase 1/2

Edad 9 hanggang 20 · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07061574

Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study

Hoag Memorial Hospital, Newport Beach
University of California, San Francisco (UCSF), San Francisco

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT07676565

Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes

City of Hope Medical Center, Duarte

Nagre-recruitPhase 1/2

Edad 18 hanggang 68 · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT03746769

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

University of California San Francisco Benioff Children's Hospital, San Francisco

Nagre-recruitPhase 2

Edad 5 hanggang 40 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07187531

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Orally Administered TIX100 in Healthy Subjects

ProSciento, INC, Chula Vista

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07675590

App-Based Certified Diabetes Education Therapy (AB-CDE)

University of Southern California, Los Angeles

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07282639

Type 1 Diabetes Extension Study

UCSF School of Medicine, San Francisco
Stanford University, Stanford

Nagre-recruitObservasyonal na pag-aaral

Edad 8 hanggang 35 · Lahat ng kasarian · Na-update Set 18, 2026 · NCT02734277

The iLet Experience Study

Beta Bionics, Irvine

Nagre-recruitObservasyonal na pag-aaral

Edad 6 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06891898

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

University of California San Francisco, San Francisco

Nagre-recruitPhase 2

Edad 8 hanggang 45 · Lahat ng kasarian · Na-update Set 8, 2026 · NCT07142252

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

City of Hope, Duarte
University of California San Francisco, San Francisco

Nagre-recruitPhase 3

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04786262

HLA Demographics Study in Adults With Type 1 Diabetes

University of California, San Francisco, San Francisco

Nagre-recruitObservasyonal na pag-aaral

Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT06860516

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

Children's Hospital Los Angeles, Los Angeles
University of California San Francisco, San Francisco

Nagre-recruitPhase 2

Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT07224321

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

University of Southern California, Los Angeles
Sansum Diabetes Research Institute, Santa Barbara

Nagre-recruit

Edad 14 hanggang 75 · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07579702

Commercial or Open Source Closed Loop Impact on Pregnancy Study

University of California, San Francisco, San Francisco

Nagre-recruitObservasyonal na pag-aaral

Edad 18 pataas · Kababaihan · Na-update Hul 27, 2026 · NCT06654713

Automated Insulin for Management of Intrapartum Glycemia

University of California, Los Angeles, Los Angeles
University of California, San Diego, San Diego
University of California, San Francisco, San Francisco

Nagre-recruit

Edad 18 hanggang 55 · Kababaihan · Na-update Hul 13, 2026 · NCT06883344

ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

Scripps Whittier Diabetes Institute, San Diego

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update May 29, 2026 · NCT04933851

Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature

Headlands Research - AMCR Institute, Escondido

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 21, 2026 · NCT07386340

Registry for Stage 2 Type 1 Diabetes

University of California Los Angeles Health- Site Number : 8400020, Los Angeles
University of California San Francisco - Mission Bay- Site Number : 8400005, San Francisco

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT06481904

Accuracy and Precision of the Continuous Glucose Monitoring System 'CareSens Air 3' in Adult Patients With T1DM

Headlands Research AMCR, Escondido
Diablo Clinical Research, Walnut Creek

Nagre-recruit

Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 9, 2026 · NCT07296276

Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

Diablo Clinical Research Center, Walnut Creek

Nagre-recruitPhase 2

Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Abr 6, 2026 · NCT06964087

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Stanford University Medical Center, Stanford

Nagre-recruitPhase 3

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT06217302

Use of CGM in Kidney Transplant Recipients

UC Davis Health, Sacramento

Nagre-recruit

Edad 18 pataas · Lahat ng kasarian · Na-update Ene 29, 2026 · NCT04783441

A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States

Investigational Site, San Francisco

Nagre-recruitObservasyonal na pag-aaral

Edad 8 pataas · Lahat ng kasarian · Na-update Dis 3, 2025 · NCT07260110

High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy

Retina Consultants of Orange County, Fullerton

Nagre-recruitPhase 4

Edad 21 pataas · Lahat ng kasarian · Na-update Hul 10, 2025 · NCT06662994

TrialNet Pathway to Prevention of T1D

Childrens Hospital of Orange County, Orange
University of California San Francisco, San Francisco
Stanford University Medical Center, Stanford

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 2 hanggang 45 · Lahat ng kasarian · Na-update Hul 1, 2025 · NCT00097292

Acetazolamide in Persons With Type 1 Diabetes - Crossover Trial

UC San Diego Altman Clinical & Translational Research Institute, La Jolla

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2025 · NCT06981234

Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes

University of California-Davis, Sacramento

Nagre-recruit

Edad 5 hanggang 18 · Lahat ng kasarian · Na-update Mar 27, 2025 · NCT04428658

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.